Disc Medicine Announces Presentation of Clinical Data from First-in-Human Phase 1 Study of DISC-0974 at European Hematology Association (EHA) 2022 Congress - Arix Bioscience

Close Navigation

About Strategy Team Portfolio Insights Media Contact

Overlay

Disc Medicine Announces Presentation of Clinical Data from First-in-Human Phase 1 Study of DISC-0974 at European Hematology Association (EHA) 2022 Congress

16th May 2022

Portfolio

This post references, or is about Disc Medicine. Find out more by clicking below

Cambridge, USA

Useful Tools

Download, print or share this article

Print

Print Article Email

Email

Print

Share Article